Agreed. What's also interesting is ATNM doesn't need the $5M. They already had $19M cash on balance sheet and even with Phase II for Iomab-B, they were well-funded thru the rest of this year and into next.
So I think this could be the start of future investments by Dr. Frost, some collaborative agreement to speed R&D, who knows?
What we do know is that ATNM definitely didn't need the funds here, so I think this investment is a precursor to something down the road.